Maravai LifeSciences
MRVI
MRVI
234 hedge funds and large institutions have $4.51B invested in Maravai LifeSciences in 2022 Q1 according to their latest regulatory filings, with 53 funds opening new positions, 79 increasing their positions, 79 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
234
Holders Change
+6
Holders Change %
+2.63%
% of All Funds
3.7%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
53
Increased
79
Reduced
79
Closed
45
Calls
$14M
Puts
$3.13M
Net Calls
+$10.9M
Net Calls Change
+$4.01M
Top Buyers
| 1 |
NC
Nekton Capital
London,
United Kingdom
|
+$39.2M |
| 2 |
N
Natixis
Paris,
France
|
+$35.3M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$33.9M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$30.9M |
| 5 |
OCBV
Ownership Capital B.V.
Amsterdam,
Netherlands
|
+$26.5M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$115M |
| 2 |
UBS AM
Chicago,
Illinois
|
-$62.8M |
| 3 |
Select Equity Group
New York
|
-$50.9M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$37.6M |
| 5 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$17.3M |
